Home › Biogen is crashing after cutting the outlook for its blockbuster drug
 

Keywords :   


Biogen is crashing after cutting the outlook for its blockbuster drug

2015-07-24 22:19:24| Biotech - Topix.net

Biogen shares fell more than 19% on Friday after quarterly earnings results that beat on profits but missed on revenues. Also, the biotech giant lowered its forecast for full-year earnings and sales because it doesn't expect Tecfidera, its key multiple sclerosis drug, to grow as expected.

Tags: its drug cutting outlook

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.11Irritants could disrupt U.S., Mexico trade relationship
08.11Irritants could disrupt U.S., Mexico trade relationship
08.11Atlantic Tropical Weather Outlook
08.11Eastern North Pacific Tropical Weather Outlook
08.11African swine fever, labor and trade top of mind for Canadian pork industry
08.11Tech giants dominate U.S. streaming platform market
08.11Warner Bros. Discovery adds 7.2 million DTC subscribers in 3Q 2024
08.11Polyurea-Based Lining is Key to GRE Pipeline Rehab Project in UAE
More »